George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDukemount Capi. Regulatory News (DKE)

Share Price Information for Dukemount Capi. (DKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.031
Bid: 0.027
Ask: 0.035
Change: 0.00 (0.00%)
Spread: 0.008 (29.63%)
Open: 0.031
High: 0.031
Low: 0.031
Prev. Close: 0.031
DKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further Funding and Funding Restructuring

11 Oct 2022 07:00

RNS Number : 4622C
Dukemount Capital PLC
11 October 2022
 

Dukemount Capital Plc11th October 2022

 

Dukemount Capital Plc

 ("Dukemount" or the "Company")

Further Funding and Funding Restructuring

 

Dukemount announces that, further to the disposal of the peakers as announced on 5 October 2022, the lenders (as detailed in the announcement of 15 September 2021) (the "Investors") have agreed to advance (the "Further Advance") the net proceeds of £50,000 in aggregate in addition to restructuring their existing funding arrangement. The maturity date for the existing debt plus the Further Advance is to be 24 months from the date of the Advance (being 10 October 2024).

 

The proceeds of the Further Advance have been used to settle accrued liabilities of the Company.

 

The board has taken steps to ensure that the financial position and prospects of the Company are maintained to facilitate a future reverse transaction. To that end, the board confirm the following has been undertaken:

- Geoffrey Dart and Paul Gazzard have released the Company from all accrued but unpaid emoluments;

- Chesterfield Capital Limited have confirmed that the outstanding balance of £500,000 due to Chesterfield Capital Limited will be converted at the previously announced subscription price of 0.65p. Such subscription to settle all balances due from the Company and to be settled by the issuance of shares at the earlier of (a) the approval of a prospectus, (b) the direction of the board of the Company and (c) 11 April 2023.

 

Terms of the Restructuring and the Further Advance

 

The key terms of the restructuring and the Further Advance being:

- 24 month term for the balances

- The debt is convertible at the nominal value of 0.1p of the ordinary shares of the Company

- The further advance is subject to the previously announced 5% implementation fee

- The Company has agreed to settle a 9.5% extension fee of £74,575 to the Noteholders in the form of ordinary shares at nominal value

 

Paul Gazzard CEO, comments "we are happy to work with the Investors to ensure that the Company is financed for the next steps as we work towards identifying a suitable reverse takeover target which will be for the benefit of all the investors who have committed to the work we have sought to do with the Company. We hugely appreciate the further support and capital injection from the Investors which, alongside our personal releases, we believe the Company to be well positioned for the immediate steps of securing a transaction. We expect to announce further updates on this process in the coming weeks"

 

 

Market Abuse Regulation (MAR) disclosure

 

Certain statements in this announcement contain inside information for the purpose of Article 7 of EU Regulation 596/2014.

 

For further information, please visit www.dukemountcapitalplc.com or contact:

 

Dukemount Capital Plc

Geoffrey Dart / Paul Gazzard

Media Enquries

 

Miriad Media, Zak Mir

Tel: +44 (0)7867 527 659

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REPGPGCCUUPPUAG
Date   Source Headline
18th Apr 20243:09 pmRNSResult of AGM
21st Mar 20247:00 amRNSNotice of AGM and a conditional subscription
8th Mar 20244:29 pmRNSTR-1: Standard form notification of major holdings
7th Mar 202410:51 amRNSUpdate on the Facility Agreement and TVR
5th Mar 202412:45 pmRNSHolding(s) in Company
4th Mar 20241:16 pmRNSCapitalisation of Loan, Issue of Equity & Warrants
26th Feb 202410:04 amRNSHolding(s) in Company
30th Jan 202412:09 pmRNSFinal Results
12th Jan 20242:13 pmRNSResult of AGM
14th Dec 20239:56 amRNSNotice of AGM
12th Sep 20237:44 amRNSProposed lifting of suspension and other updates
16th Jun 20237:00 amRNSHalf-year Report
9th Jun 202310:17 amRNSFinal Results
22nd Nov 20227:06 amRNSChange of Broker
1st Nov 20228:03 amRNSTemporary Suspension
28th Oct 20224:40 pmRNSSecond Price Monitoring Extn
28th Oct 20224:35 pmRNSPrice Monitoring Extension
28th Oct 20229:32 amRNSIssue of Equity
27th Oct 20224:41 pmRNSSecond Price Monitoring Extn
27th Oct 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20229:32 amRNSIssue of Equity
20th Oct 20229:26 amRNSIssue of Equity
19th Oct 202212:33 pmRNSHolding(s) in Company
19th Oct 20227:00 amRNSHolding(s) in Company
13th Oct 20222:05 pmRNSSecond Price Monitoring Extn
13th Oct 20222:00 pmRNSPrice Monitoring Extension
13th Oct 202211:05 amRNSSecond Price Monitoring Extn
13th Oct 202211:00 amRNSPrice Monitoring Extension
12th Oct 20227:00 amRNSIssue of Equity
11th Oct 20227:00 amRNSFurther Funding and Funding Restructuring
5th Oct 20229:05 amRNSSecond Price Monitoring Extn
5th Oct 20229:00 amRNSPrice Monitoring Extension
5th Oct 20227:20 amRNSCompletion of sale
23rd Feb 20224:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:35 pmRNSPrice Monitoring Extension
28th Jan 20221:43 pmRNSInterim Results
4th Jan 20224:36 pmRNSHolding(s) in Company
29th Oct 20212:16 pmRNSFinal Results
7th Oct 202110:08 amRNSChange of Broker
4th Oct 20217:19 amRNSCompletion of Purchase of Energy Generation Sites
27th Sep 202110:44 amRNSHolding(s) in Company
15th Sep 20217:32 amRNSCompletion of Gas Peaking Funding
17th Aug 202110:55 amRNSHolding(s) in Company
10th Aug 202110:03 amRNSUpdate Re Funding
19th Jul 20217:00 amRNSHolding(s) in Company
19th Jul 20217:00 amRNSHolding(s) in Company
15th Jul 202111:19 amRNSResult of GM
30th Jun 20212:06 pmRNSSecond Price Monitoring Extn
30th Jun 20212:00 pmRNSPrice Monitoring Extension
29th Jun 20213:42 pmRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.